Literature DB >> 22230943

Compartmental differences of circulating tumor cells in colorectal cancer.

Nuh N Rahbari1, Ulrich Bork, Alexandra Kircher, Thomas Nimitz, Sebastian Schölch, Christoph Kahlert, Thomas Schmidt, Gunnar Steinert, Alexis B Ulrich, Christoph Reissfelder, Markus W Büchler, Moritz Koch, Jürgen Weitz.   

Abstract

BACKGROUND: The prognostic role of circulating tumor cells (CTCs) has been established for colorectal cancer (CRC). We investigated the qualitative and quantitative detection of CTC in the central (CVBC) and mesenteric (MVBC) venous blood compartments to elucidate the patterns of hematogenous tumor cell dissemination in patients with CRC.
METHODS: A total of 200 patients were enrolled prospectively. Blood samples were collected from the tumor-draining vein and via a central venous line. CTCs were detected and quantified by using the CellSearch system. Factors associated with CTC detection in both compartments were analyzed by using univariate and multivariate analyses.
RESULTS: CTC analyses were performed in the CVBC and MVBC in 200 and 80 patients, respectively. CTCs were found at a higher rate (P=0.01) and at a higher count (P=0.006) in the MVBC compared with the CVBC. On multivariate analyses, stage IV disease (odds ratio, 3.83; 95% confidence interval, 1.42-10.35) and increased preoperative carbohydrate antigen 19-9 level (odds ratio, 3.57; 1.30-9.79) were associated with CTC detection in the CVBC. CTCs were detected more frequently (P=0.05) and at higher numbers (P=0.05) in the CVBC of patients with low compared with mid or high rectal tumors.
CONCLUSIONS: The qualitative and quantitative detection of CTCs is higher in the MVBC compared with the CVBC of patients with CRC.

Entities:  

Mesh:

Year:  2012        PMID: 22230943     DOI: 10.1245/s10434-011-2178-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  34 in total

1.  Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.

Authors:  Vasudha Murlidhar; Rishindra M Reddy; Shamileh Fouladdel; Lili Zhao; Martin K Ishikawa; Svetlana Grabauskiene; Zhuo Zhang; Jules Lin; Andrew C Chang; Philip Carrott; William R Lynch; Mark B Orringer; Chandan Kumar-Sinha; Nallasivam Palanisamy; David G Beer; Max S Wicha; Nithya Ramnath; Ebrahim Azizi; Sunitha Nagrath
Journal:  Cancer Res       Date:  2017-07-17       Impact factor: 12.701

2.  Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.

Authors:  Jussuf T Kaifi; Miriam Kunkel; David T Dicker; Jamal Joude; Joshua E Allen; Avisnata Das; Junjia Zhu; Zhaohai Yang; Nabeel E Sarwani; Guangfu Li; Kevin F Staveley-O'Carroll; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 3.  Clinical applications of liquid biopsies in gastrointestinal oncology.

Authors:  Jason Zhu; John H Strickler
Journal:  J Gastrointest Oncol       Date:  2016-10

4.  Aberrant single metastasis to the elbow from primary rectal cancer: a rare presentation.

Authors:  Alessandro Bianchi; Marina Jimenez-Segovia; Jaume Bonnin-Pascual; Marga Gamundí-Cuesta; Myriam Fernandez-Isart; Monica Guillot-Morales; Diego Salinas-Gonzalez; Xavier Francesc Gonzalez-Argenté
Journal:  Pan Afr Med J       Date:  2020-08-31

5.  Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients.

Authors:  Jussuf T Kaifi; Miriam Kunkel; Junjia Zhu; David T Dicker; Niraj Gusani; Zhaohai Yang; Nabeel E Sarwani; Guangfu Li; Eric T Kimchi; Kevin F Staveley-O'Carroll; Wafik S El-Deiry
Journal:  Cancer Biol Ther       Date:  2013-10-23       Impact factor: 4.742

Review 6.  Prognostic relevance of minimal residual disease in colorectal cancer.

Authors:  Ulrich Bork; Robert Grützmann; Nuh N Rahbari; Sebastian Schölch; Marius Distler; Christoph Reissfelder; Moritz Koch; Jürgen Weitz
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 7.  Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?

Authors:  Olga A Martin; Robin L Anderson; Kailash Narayan; Michael P MacManus
Journal:  Nat Rev Clin Oncol       Date:  2016-08-23       Impact factor: 66.675

Review 8.  [Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP)].

Authors:  E Dahl; A Jung; J Fassunke; M Hummel; R Penzel; W Dietmaier; S Laßmann
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

9.  Development of a quantum-dot-labelled magnetic immunoassay method for circulating colorectal cancer cell detection.

Authors:  Maria Gazouli; Anna Lyberopoulou; Pericles Pericleous; Spyros Rizos; Gerassimos Aravantinos; Nikolaos Nikiteas; Nicholas P Anagnou; Efstathios P Efstathopoulos
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

10.  Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients.

Authors:  Johannes C Fischer; Dieter Niederacher; Stefan A Topp; Ellen Honisch; Sarah Schumacher; Norma Schmitz; Luisa Zacarias Föhrding; Christian Vay; Imke Hoffmann; Nikola S Kasprowicz; Philip G Hepp; Svjetlana Mohrmann; Ulrike Nitz; Antje Stresemann; Thomas Krahn; Tanja Henze; Evelyn Griebsch; Katharina Raba; Jutta M Rox; Folker Wenzel; Christoph Sproll; Wolfgang Janni; Tanja Fehm; Christoph A Klein; Wolfram Trudo Knoefel; Nikolas H Stoecklein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.